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Morphological changes in functional tricuspid regurgitation on contrast-enhanced computed 2 
tomography correlates to tricuspid regurgitation grade 3 
 4 
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PURPOSE: To examine the relationship between each severity of functional tricuspid 23 





METHODS: Forty-five patients underwent contrast-enhanced CT. Tricuspid annulus area 25 
(TAA), tricuspid annulus circumference (TAC), right ventricular volume (RVV), and the 26 
distances between the tips and bases of the papillary muscles were measured on contrast-27 
enhanced CT in diastole and systole.  The patients were classified organized into 4 groups by 28 
TR grade measured by transthoracic echocardiography (none+trivial: 26, mild: 6, moderate: 6, 29 
severe: 7), and the data were compared among the groups. 30 
RESULTS: In parameters measured on contrast-enhanced CT images, TAA, TAC, and the 31 
distances between the tips of the anterior and posterior papillary muscles in both diastole and 32 
systole and RVV in diastole were significantly different among the groups (p<0.05). 33 
Parameters that had correlations with TR grade were TAA, TAC, RVV and the distances 34 
between the tips of the anterior and posterior papillary muscles in both diastole and systole 35 
(r>0.40). The septal papillary muscle could not be identified in about 1/3 (35.6%) of cases. 36 
CONCLUSIONS: TAA, TAC, RVV, and the distance between the tips of the anterior and 37 
posterior papillary muscles measured on contrast-enhanced CT images had relatively positive 38 
correlations with TR grade.  39 
 40 
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Functional tricuspid regurgitation (FTR) occurs from morphological changes of the tricuspid 47 
valve complex that develop secondary to tricuspid annulus dilation and ventricular 48 





disease, such as valvular failure 1-5). FTR severity is diagnosed by transthoracic 50 
echocardiography and estimated semiquantitatively using the range or area of the regurgitant 51 
jet1). Transthoracic echocardiography is performed easily, and a past study evaluated 52 
morphological changes of the tricuspid valve complex by transthoracic echocardiography 6). 53 
However, transthoracic echocardiography has some limitations, such as the need for the 54 
evaluator to have experience and limited ultrasound examination by ribs or air. 55 
On the other hand, contrast-enhanced computed tomography (CT) is also performed easily 56 
and is useful for morphological assessment. Recently, detailed preoperative morphological 57 
assessment using contrast-enhanced CT has become possible, for example, for transcatheter 58 
aortic valve implantation (TAVI) 7-9). However, few papers have considered morphological 59 
assessment of FTR using contrast-enhanced CT. 60 
We postulated that, in FTR, morphological changes of tricuspid annulus area (TAA), 61 
tricuspid annulus circumference (TAC), right ventricular volume (RVV), and the distance 62 
between papillary muscles could be identified on contrast-enhanced CT images. The aim of 63 
this study was to evaluate the morphological changes in FTR cases using contrast-enhanced 64 
CT. 65 
 66 
Materials and methods 67 
Study population 68 
Between April 2018 and July 2019, 45 patients planned for cardiovascular surgery 69 
underwent contrast-enhanced CT and transthoracic echocardiography. Patients who had 70 
primary tricuspid regurgitation, de novo myocardial infarction within less than 28 days, 71 
unstable angina, end-stage renal failure, infective endocarditis, active hemorrhagic diseases 72 





excluded. This study was approved by the research ethics committee of Sapporo Medical 74 
University. 75 
The 45 cases were divided into 4 groups by TR grade measured by transthoracic 76 
echocardiography (none+trivial: 26 cases, mild: 6 cases, moderate: 6 cases, severe: 7 cases), 77 
and then differences among groups were examined. The correlations of TR grade and 78 
contrast-enhanced CT measurements were also examined. 79 
 80 
Contrast-enhanced computed tomography 81 
ECG-gated 320-detector-row multislice computed tomography (Aquilion one, Toshiba 82 
Medical Systems, Tokyo, Japan) was used for this study. In order to ensure that the tricuspid 83 
annulus and right ventricle would be clearly depicted, very early phase images were taken. 84 
The reconstructed volume data images were transferred to OsiriX (Pixmeo, Geneva, 85 
Switzerland) and Ziostation2 (Ziosoft, Tokyo, Japan). TAA, TAC, RVV, and the distances 86 
between papillary muscles (anterior, posterior, and septal, and each distance of tips [t] and 87 
bases [b]) were measured on contrast-enhanced CT images. Each was measured at diastole (d) 88 
and at systole (s). For example, the distance between the tips of the anterior and posterior 89 
papillary muscles is shown as dtAP. Figure 1 shows the measurements. 90 
 91 
Transthoracic echocardiography  92 
A Philips iE33 (Koninklijke Philips N.V., Amsterdam, Netherlands) was used for this study. 93 
General measurements, TR grade, and tricuspid annulus diameter (TA, end-diastole, 4-94 
chamber view) were measured. 95 
 96 





One-way ANOVA was performed to evaluate the mean differences among the four groups, 98 
and p<0.05 was considered significant. When significant differences were found, the multiple 99 
comparison method was used to examine differences between groups; when the parameter 100 
could be assumed to have equal dispersion, the Tukey method was used, and when not, the 101 
Games-Howell method was used. Pearson’s correlation coefficient was calculated between 102 
groups, and p<0.05 was considered significant. In addition, all cases were divided into the non 103 
FTR group (none + trivial + mild) and the FTR group (moderate + severe), and risk factors 104 
for FTR ≥ moderate were evaluated by multiple logistic regression analysis. The dependent 105 
variable was FTR ≥ moderate or not, and the independent variables were age, body surface 106 
area, diastolic and systolic TAA, TAC, RVV, and the distances between the tips and bases of 107 
the anterior and posterior papillary muscles, which were measurable in all cases. Independent 108 
variables were chosen by the variable increase method (likelihood ratio). All statistical 109 
analyses were performed using IBM SPSS Statistics version 25.0 (IBM, Armonk, NY, USA). 110 
 111 
Results 112 
Table 1 shows the patients’ characteristics and parameters measured on contrast-enhanced CT 113 
images and transthoracic echocardiography for every TR grade. Age and body surface area 114 
did not show significant differences. 115 
As for TAA, TAC, and RVV measured on contrast-enhanced CT images, dTAA, sTAA, 116 
dTAC, sTAC, and dRVV showed significant differences among the groups (p<0.01). Figures 117 
2, 3, and 4 show box-and-whisker plots and correlations with the TR grade of TAA, TAC, and 118 
RVV. All parameters had correlations with TR grade (r>0.5). 119 
With respect to the distances between papillary muscles measured on contrast-enhanced CT 120 
images, dtAP, stAP, dbAP, dtPS, dbPS, and sbPS showed significant differences among the 121 





In addition, as a subgroup analysis, all cases were divided into the non FTR group (none + 123 
trivial + mild) and the FTR group (moderate + severe), and risk factors for FTR ≥ moderate 124 
were evaluated by multiple logistic regression analysis (Table 2). Risk factors were selected 125 
by the variable increase method (likelihood ratio), and the only risk factor identified was 126 
sTAA, with an odds ratio of 1.77 [95% confidence interval 1.26-2.49]. 127 
 128 
Discussion 129 
TAA, TAC, and RVV measured on contrast-enhanced CT images had relatively positive 130 
correlations with the TR grade measured by transthoracic echocardiography, showing that 131 
tricuspid annulus dilation and ventricular enlargement are causes of FTR progression. 132 
Furthermore, the correlation coefficients of dTAA, sTAA, dTAC, sTAC, and dRVV were 133 
higher than the correlation coefficient of TA measured by transthoracic echocardiography 134 
(r=0.624), and it appeared that parameters measured on contrast-enhanced CT images had 135 
stronger correlations with TR grade than TA measured by transthoracic echocardiography. 136 
With respect to the distances between papillary muscles, dtAP, dbAP, and stAP showed 137 
significant differences among the groups, and dtAP had a particularly positive correlation 138 
with TR grade (r=0.484). Although it is not as related as TAA, TAC, and RVV, it is thought 139 
that tAP tends to expand as FTR becomes severe. 140 
In about 1/3 (35.6%) of cases, the septal papillary muscle could not be identified on contrast-141 
enhanced CT. According to autopsy reports, cases with many small septal papillary muscles 142 
or tendinous cords that appear directly from the septal walls of the right ventricle have been 143 
described, and there are many variations of septal papillary muscles 10). The present study was 144 
similar, and there were many cases in which septal muscles could not be identified because of 145 
the many variations. Anterior and posterior papillary muscles were identified in all cases; only 146 





cases, the posterior papillary muscle was also small, and only the anterior papillary muscle 148 
was clearly visible, so it is thought that the anterior papillary muscle contributes most to the 149 
tricuspid valve.  150 
On multiple logistic regression analysis as a subgroup analysis, sTAA contributed most to 151 
FTR ≥ moderate. This is because tricuspid regurgitation occurs during systole, and it is 152 
thought that sTAA contributes to FTR. Generally, the tricuspid annulus is measured in end-153 
diastole by transthoracic echocardiography, but one study pointed out that the tricuspid 154 
annulus should be measured in systole 11), with which we agree. Measurement of tricuspid 155 
annulus diameter and determination of ring size should be done in systole. 156 
Kabasawa et al. also evaluated FTR by contrast-enhanced CT 12) in 35 patients who 157 
underwent contrast-enhanced CT, and end-diastolic and end-systolic tricuspid valve annular 158 
diameters (TVADs), tethering angles, and tethering height were significantly correlated with 159 
preoperative TR severity. The result for the tricuspid annulus was similar to that of the present 160 
study, and the present study did not evaluate tethering angles and tethering height, but 161 
evaluated the distances between papillary muscles and right ventricular volume. 162 
In comparison with sonography, contrast-enhanced CT is slightly more invasive because of 163 
the use of contrast media and radiation exposure. However, contrast-enhanced CT is useful  164 
because it can perform morphological evaluations, especially quantitative measurement, 165 
objectively and in detail. In the present study, the detailed morphological assessment of FTR 166 
was possible using contrast-enhanced CT. 167 
The present study has some limitations. First, we did not evaluate the change over time for 168 
each patient. We will evaluate the morphological changes and surgical indications for FTR in 169 





Secondly, the tricuspid annulus actually has three-dimensional geometry 13, 14). However, in 171 
the present study, the true annulus structure might not been evaluated, because the tricuspid 172 
annulus was measured in a section of contrast-enhanced CT. 173 
Thirdly, the present study depended mainly on morphological examination on contrast-174 
enhanced CT, and other aspects of the cases were not considered. For example, there has been 175 
a report that a huge left atrium or atrial fibrillation is a risk factor for late TR after surgery15), 176 
and further studies are needed to evaluate patients’ status in greater detail. 177 
 178 
Conclusions 179 
TAA, TAC, RVV, and the distances between papillary muscles (especially tAP), measured 180 
on contrast-enhanced CT images, had relatively positive correlations with TR grade measured 181 
by transthoracic echocardiography.  182 
Detailed morphological assessment of functional tricuspid regurgitation is possible using 183 
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FIGURES  242 
 243 
Figure 1. a) Tricuspid annulus area and tricuspid annulus circumference, b) Right ventricular 244 








Figure 2. Box-and-whisker plots of diastolic (a) and systolic (b) tricuspid annulus area 249 
 250 
 251 
Figure 3. Box-and-whisker plots of diastolic (a) and systolic (b) tricuspid annulus 252 
circumference 253 
 254 







Table 1. Patient’s characteristics and parameters measured on contrast- enhanced CT and 258 
transthoracic echocardiography 259 
 All cases 
(n=45) 
None + Trivial 
(n=26) 
Mild (n=6) Moderate (n=6) Severe (n=7) p value r p value 
of r 
Age (y) 73.2±9.5 72.0±11.4 72.5±6.2 76.3±4.0 75.4±7.5 0.699 0.167 0.272 
Body height (cm) 160.5±8.5 160.7±8.0 159.4±10.2 161.5±7.0 159.8±11.3 0.971 -0.022 0.887 
Body weight (kg) 58.8±10.1 59.4±8.6 57.2±12.2 56.2±6.5 60.5±16.2 0.782 -0.013 0.931 
Body surface area 
(cm2) 
1.61±0.16 1.62±0.14 1.58±0.18 1.59±0.098 1.62±0.26 0.909 -0.027 0.862 
Enhanced CT   
dTAA (cm2) 14.2±4.3 12.2±2.2* 13.4±2.2 16.9±3.8 20.0±5.6* 0.012 0.685 <0.001 
sTAA (cm2) 12.3±4.3 10.2±2.3*,** 11.2±3.0† 15.0±3.1** 18.5±4.9*,† 0.003 0.772 <0.001 
dTAC (mm) 137.4±18.1 128.9±11.0* 136.2±11.4 148.5±16.6 160.3±22.9* <0.001 0.656 <0.001 
sTAC (mm) 127.2±20.2 117.7±12.5*,** 123.0±15.8† 140.5±14.9** 155.1±21.4*,† <0.001 0.696 <0.001 
dRVV (mL) 161.5±77.7 129.6±38.0* 118.5±27.3† 197.6±53.5 286.1±97.9*,† 0.003 0.704 <0.001 
sRVV (mL) 108.6±59.0 86.1±29.9* 93.1±34.2 139.4±66.0 178.8±89.9* 0.074 0.582 <0.001 
dtAP (mm) 26.0±5.2 23.7±4.4*,** 28.0±2.0 29.5±7.0** 29.4±4.2* 0.005 0.484 0.001 
stAP (mm) 19.9±4.8 18.1±4.7* 21.3±2.0 21.8±6.1 23.4±2.9* 0.024 0.433 0.003 
dbAP (mm) 29.4±6.8 27.5±5.9* 32.5±4.3 28.3±11.1 35.0±3.9* 0.015 0.348 0.019 
sbAP (mm) 24.5±6.1 23.0±5.7 27.3±3.7 23.3±8.3 28.3±6.0 0.122 0.271 0.071 
dtPS (mm) 20.2±5.2 17.5±2.6* 21.1±4.5 19.9±4.0 26.1±6.4* 0.001 0.622 <0.001 
stPS (mm) 15.3±4.6 13.6±2.7 18.7±2.8 13.2±2.9 19.3±6.4 0.185 0.443 0.016 
dbPS (mm) 25.5±7.7 21.7±6.1* 27.3±6.7 28.7±9.3 30.9±7.0* 0.031 0.516 0.003 
sbPS (mm) 20.6±6.1 18.6±4.2* 20.8±9.8 18.2±7.0 26.5±5.8* 0.02 0.472 0.010 
dtSA (mm) 32.8±5.0 32.3±3.9 27.2±1.0 33.1±4.3 36.2±6.6 0.057 0.297 0.105 
stSA (mm) 25.1±5.0 25.7±3.9 23.5±1.9 26.0±7.8 28.1±6.2 0.63 0.189 0.325 
dbSA (mm) 36.1±7.7 35.2±6.7 31.7±4.6 36.9±7.5 39.5±10.5 0.466 0.228 0.218 
sbSA (mm) 28.3±6.1 28.7±5.2 25.8±4.7 26.6±7.5 29.0±8.3 0.858 -0.014 0.942 
Transthoracic echocardiography   
TA (mm) 31.4±5.7 28.7±4.6* 30.0±2.4** 32.4±3.4 38.7±6.3*,** 0.001 0.624 <0.001 
dTAA: diastolic tricuspid annulus area  260 
sTAA: systolic tricuspid annulus area  261 
dTAC: diastolic tricuspid annulus circumference 262 
sTAC: systolic tricuspid annulus circumference  263 





sRVV: systolic right ventricular volume  265 
dtAP: diastolic anterior-posterior papillary muscles distance (tips) 266 
stAP: systolic anterior-posterior papillary muscles distance (tips) 267 
dbAP: diastolic anterior-posterior papillary muscles distance (basal) 268 
sbAP: systolic anterior-posterior papillary muscles distance (basal) 269 
dtPS: diastolic posterior-septal papillary muscles distance (tips) 270 
stPS: systolic posterior-septal papillary muscles distance (tips) 271 
dbPS: diastolic posterior-septal papillary muscles distance (bases) 272 
sbPS: systolic posterior-septal papillary muscles distance (bases) 273 
dtSA: diastolic septal-anterior papillary muscles distance (bases) 274 
stSA: systolic septal-anterior papillary muscles distance (bases) 275 
dbSA: diastolic septal-anterior papillary muscles distance (bases) 276 
sbSA: systolic septal-anterior papillary muscles distance (bases) 277 
TA: tricuspid annulus diameter (4-chamber view, diastolic) 278 
*,**,†: significant difference in p<0.05 between groups 279 
 280 
 281 
Table 2. Multivariable analysis for FTR ≥ moderate 282 
Variable Odds ratio 95% CI p value 
sTAA (cm2) 1.77 1.26-2.49 0.001 









機能性三尖弁閉鎖不全症 (FTR) 症例では造影 CT で三尖弁複合体にどのような形態学288 
的変化が認められるかを検討した. ⼼臓⼤⾎管⼿術術前患者 45 例に対し造影 CT 及び289 
経胸壁エコーを施⾏した. 造影 CT で拡張期及び収縮期の三尖弁輪⾯積, 三尖弁輪周囲290 
⻑, 右⼼室容積, 先端間及び基部間における各乳頭筋間距離を計測した. 経胸壁⼼エコ291 
ーによる TR grade ごと 4 群に分け (None + Trivial 群：26 例, Mild 群：6 例, Moderate292 
群：6 例, Severe 群：7 例), 各項⽬の有意差の有無及び, TR grade との相関関係を評価293 
した. 群間で有意差を認めた項⽬ (p>0.05) は三尖弁輪⾯積 (拡張期, 収縮期) , 三尖弁輪294 
周囲⻑ (拡張期, 収縮期) , 右⼼室容積 (拡張期) ,先端間前-後乳頭筋間距離 (拡張期, 収295 
縮期) であった. TR grade と相関関係を認めた項⽬ (r > 0.40) は三尖弁輪⾯積 (拡張期, 296 
収縮期) , 三尖弁輪周囲⻑ (拡張期, 収縮期) , 右⼼室容積 (拡張期, 収縮期) ,先端間前-後297 
乳頭筋間距離 (拡張期, 収縮期) であった. 中隔乳頭筋については約 1/3 (35.6%) の症例298 
で同定できず, 前乳頭筋, 後乳頭筋は全例で同定可能であったため, 前-後乳頭筋間距299 
離のみが有効に計測することができた. 造影 CT で計測した三尖弁輪⾯積, 三尖弁輪周300 
囲⻑, 右⼼室容積, 先端間前-後乳頭筋間距離は経胸壁⼼エコーによる TR grade と正の301 
相関を⽰した. 造影 CT で機能性三尖弁閉鎖不全症の詳細な形態学的評価が可能であ302 
った.  303 
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